VC funding trends in biotechnology | McKinsey - McKinsey & Company
WEBDec 12, 2023 · Leaders in the space, such as Moderna and BioNTech, are spending billions to advance their mRNA pipelines in a wide set of indications. On top of these large investments, VC investors are betting on even more innovation in the field with almost $250 million in VC funding in 2022.
Fierce Biotech Fundraising Tracker 2024
WEB3 days ago · A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's...
Analyzing the biotech funding landscape in 2023: U.S. still out front
WEBJan 5, 2024 · In 2023, the U.S. continued to demonstrate its position as the biotech funding leader, commanding over one-third, 35%, of the global investment in the sector. Overall, U.S. biotech firms attracted $56.79 billion in funding, according to a …
20 biotech startups attracted almost $3B in Q1 2024 funding
WEBApr 5, 2024 · The following summaries of top healthcare biotech funding recipients in Q1 2024 highlight the companies highlight a range of promising focus areas, including precision oncology, AI-driven drug discovery, cell and gene therapies and novel approaches to treating autoimmune disorders.
Biotech is riding a wave of growth in funding. What’s next?
WEBApr 30, 2021 · VC activity in biotechs grew by 45 percent in a year, taking the 2020 global total to $36.6 billion. US biotechs still led on investments, although Europe and China were not far behind. In Europe, mean funding size grew at …
Biotech financing: darkest before the dawn | Nature Biotechnology
WEBAug 8, 2024 · As biotech transitions from dark into dawn, Europe’s companies may prove more resilient than some of their US counterparts. “We’re better at getting along on less,” says Forbion’s Slootweg.
Fierce Biotech Fundraising Tracker '23
WEBDec 20, 2023 · The series A funding will help the young biotech build out its platform, which combines both covalent ligand discovery and chemical biology capabilities.
Global biotech VC trends in Q1 2024 - Drug Discovery and …
WEBApr 5, 2024 · The first quarter of 2024 saw a flurry of funding activity in the biotech sector, with early-to-mid-stage companies attracting most of the investment dollars. Among the most notable late-stage deals was blood-based cancer diagnostics firm Freenome ‘s $254 million Series E round.
Next-generation platform technologies are driving the biotech VC …
WEBJun 10, 2022 · We analyzed VC and private-equity funding from seed to series C in privately held biotech companies with deal sizes greater than $10 million from 2019 to 2021. For historical context, we also analyzed seed and series A deals in 2017 and 2018.
Biotech in 2022: Industry leaders and investors on trends and ...
WEBJan 5, 2022 · Venture capital funding for the life sciences hit record highs nationally for the 12 months ending in September, reaching more than $30 billion. In the Seattle region, companies raised a whopping...
Skip to content